Overview

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

Status:
Completed

Trial end date:
2019-02-06

Target enrollment:

Participant gender:

Summary

This study aims to demonstrate similarities between two different forms of entrectinib (A and C) when administered under fasted conditions in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Entrectinib